MabPlex International

About:

MabPlex provides CDMO services in the development and manufacturing of biopharmaceuticals.

Top Investors: OrbiMed, Apollomics, Shenzhen Capital Group, Thousand Oaks Biopharmaceuticals, Yuce Biological Technology

Description:

MabPlex provides CDMO services in the development and manufacturing of biopharmaceuticals, including mAbs, recombinant proteins, ADCs, and bispecifics. They offer partners contract services from DNA to finished drug product. They offer comprehensive biologics development and manufacturing solutions for customers globally.

Total Funding Amount:

900M CNY

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Fremont, California, United States

Founded Date:

2013-01-01

Founders:

Number of Employees:

501-1000

Last Funding Date:

2020-06-08

IPO Status:

Private

Industries: